Profile data is unavailable for this security.
About the company
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
- Revenue in USD (TTM)342.71m
- Net income in USD-59.65m
- Incorporated2019
- Employees800.00
- LocationOncology Institute Inc18000 Studebaker Rd, Suite 800CERRITOS 90703United StatesUSA
- Phone+1 (562) 735-3226
- Fax+1 (302) 636-5454
- Websitehttps://theoncologyinstitute.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Integrated Sciences Inc | 13.66m | -12.08m | 20.01m | 127.00 | -- | 0.8399 | -- | 1.46 | -0.7517 | -0.7517 | 0.8584 | 1.25 | 0.3824 | 8.70 | 8.88 | 107,543.60 | -33.86 | -29.43 | -43.28 | -35.64 | 40.35 | 39.59 | -88.55 | -110.25 | 0.4089 | -3.98 | 0.1305 | -- | 7.11 | 7.17 | 59.77 | -- | -22.73 | -- |
| Pacific Green Technologies Inc | 89.10m | 7.88m | 20.41m | 45.00 | 2.67 | 1.24 | 2.56 | 0.2291 | 0.1458 | 0.1458 | 1.81 | 0.3154 | 1.99 | -- | 53.47 | 1,979,898.00 | 15.61 | -12.03 | 48.16 | -46.78 | 27.53 | 39.68 | 7.85 | -13.35 | -- | -0.6059 | 0.122 | -- | -50.52 | 30.80 | -5.25 | -- | -73.45 | -- |
| ATI Physical Therapy Inc | 713.56m | -119.67m | 20.92m | 6.00k | -- | -- | -- | 0.0293 | -28.91 | -28.91 | 171.81 | 25.33 | 0.7005 | -- | 7.81 | 118,926.00 | -5.34 | -- | -6.12 | -- | 15.64 | -- | -7.62 | -- | -- | -0.1011 | 0.8274 | -- | 9.97 | -- | 73.20 | -- | -- | -- |
| Concord Medical Services Hldgs Ltd (ADR) | 74.21m | -41.10m | 21.71m | 727.00 | -- | -- | -- | 0.2926 | -0.9409 | -0.9409 | 1.70 | -6.75 | 0.0891 | 9.81 | 5.27 | 102,079.00 | -8.81 | -9.49 | -85.81 | -39.24 | -14.26 | -15.06 | -98.81 | -134.56 | 0.2956 | -5.70 | 0.6348 | -- | 13.84 | 23.00 | 39.21 | -- | -6.88 | -- |
| Medirom Healthcare Technologies Inc(ADR) | 26.14m | -3.93m | 24.87m | 171.00 | -- | 18.99 | -- | 0.9513 | -0.9485 | -0.9485 | 5.88 | 0.2683 | 0.8847 | 406.62 | 10.40 | 152,892.80 | -13.29 | -- | -25.58 | -- | 17.03 | -- | -15.03 | -- | 0.3519 | -53.29 | 0.7856 | -- | -14.50 | -- | -3,210.30 | -- | -- | -- |
| Exagen Inc | 55.73m | -19.36m | 33.88m | 174.00 | -- | 1.69 | -- | 0.6079 | -1.09 | -1.09 | 3.13 | 1.15 | 0.8572 | -- | 5.52 | 320,304.60 | -29.78 | -30.21 | -34.58 | -33.75 | 58.76 | 54.86 | -34.74 | -55.36 | -- | -8.07 | 0.4998 | -- | 15.33 | 10.13 | 50.01 | -- | 33.00 | -- |
| Nutex Health Inc | 258.77m | -41.00m | 33.93m | 800.00 | -- | 0.5385 | -- | 0.1311 | -0.9175 | -0.9175 | 5.71 | 1.27 | 0.6203 | 67.70 | 4.41 | 323,463.30 | -8.88 | -69.35 | -10.70 | -84.85 | 15.49 | 10.97 | -14.32 | -102.85 | 1.63 | 0.2489 | 0.7617 | -- | 12.93 | 428.22 | 89.22 | -- | -- | -- |
| Oncology Institute Inc | 342.71m | -59.65m | 36.79m | 800.00 | -- | 0.8893 | -- | 0.1073 | -0.8066 | -0.8066 | 4.63 | 0.5557 | 1.56 | 26.16 | 6.55 | 428,391.30 | -33.23 | -- | -40.16 | -- | 16.76 | 19.54 | -21.29 | -9.99 | 2.83 | -7.94 | 0.6816 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 4.75m | 6.40% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.76m | 2.38% |
| Balyasny Asset Management LPas of 31 Mar 2024 | 1.73m | 2.32% |
| Kent Lake Capital LLCas of 31 Mar 2024 | 1.19m | 1.60% |
| Triatomic Management LPas of 31 Mar 2024 | 884.69k | 1.19% |
| Cincinnati Financial Corp. (Investment Portfolio)as of 31 Mar 2024 | 699.50k | 0.94% |
| Tiff Advisory Services LLCas of 31 Mar 2024 | 423.41k | 0.57% |
| Geode Capital Management LLCas of 31 Mar 2024 | 354.10k | 0.48% |
| FourWorld Capital Management LLCas of 31 Mar 2024 | 250.36k | 0.34% |
| Element Pointe Advisors LLCas of 31 Mar 2024 | 199.03k | 0.27% |
